PRESS RELEASE published on 05/17/2024 at 19:32, 2 years 5 months ago Sartorius Stedim Biotech Capital Markets: Links to presentation and webcast Sartorius Stedim Biotech presented its business strategy and goals during Capital Markets Day, reaffirming its 2024 forecast and medium-term ambitions up to 2028. Links to presentation and webcast provided for broad access Business Strategy Webcast Forecast Sartorius Stedim Biotech Capital Markets Day
BRIEF published on 05/02/2024 at 15:39, 2 years 5 months ago Sartorius Stedim Biotech Announces Share and Voting Rights Update Share Capital Voting Rights Financial News Corporate Governance Sartorius Stedim Biotech
PRESS RELEASE published on 05/02/2024 at 15:34, 2 years 5 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares the number of shares and voting rights comprising the issued capital as of April 30, 2024 Voting Rights Shares Sartorius Stedim Biotech SA Issued Capital French Regulatory News
BRIEF published on 04/18/2024 at 07:07, 2 years 6 months ago Sartorius Stedim Biotech reveals its results for the first quarter of 2024 Financial Results Biopharmaceutical Global Market Taking Orders Economic Projections
PRESS RELEASE published on 04/18/2024 at 07:02, 2 years 6 months ago Sartorius Stedim Biotech publishes unaudited first quarter results for 2024 Sartorius Stedim Biotech publishes unaudited first quarter results for 2024, showing sales revenue of 667 million euros and order intake up 13.9 percent. Full-year outlook confirmed amidst global uncertainties Order Intake Sartorius Stedim Biotech Sales Revenue First Quarter Results Full-year Outlook
BRIEF published on 04/02/2024 at 15:40, 2 years 6 months ago Sartorius Stedim Biotech announces its capital structure and voting rights for March 2024 Share Capital Voting Rights Actions Transparency Sartorius Stedim Biotech
PRESS RELEASE published on 04/02/2024 at 15:35, 2 years 6 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares the number of shares and voting rights in the issued capital as of March 31, 2024. This announcement complies with relevant regulatory requirements Voting Rights Shares Sartorius Stedim Biotech SA Regulatory Announcement Issued Capital
BRIEF published on 03/26/2024 at 16:23, 2 years 7 months ago Resolutions Passed at Sartorius Stedim Biotech's Annual Shareholders’ Meeting Board Of Directors Dividend Sartorius Stedim Biotech Biopharmaceutical Industry Annual Shareholders’ Meeting
PRESS RELEASE published on 03/26/2024 at 16:18, 2 years 7 months ago Resolutions of the Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A. Sartorius Stedim Biotech S.A. shareholders approve resolutions and dividend proposal at Annual Shareholders' Meeting. Board composition updated Dividend Proposal Sartorius Stedim Biotech S.A. Resolutions Annual Shareholders' Meeting Board Composition
BRIEF published on 03/01/2024 at 14:27, 2 years 7 months ago Sartorius Stedim Biotech SA Updates on Shares and Voting Rights Voting Rights Shares Sartorius Stedim Biotech Regulatory Announcement Issued Capital
Published on 10/30/2026 at 23:35, 1 day 1 hour ago Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 1 day 1 hour ago Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 19:00, 1 day 6 hours ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 1 day 9 hours ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 10/31/2026 at 16:35, 8 hours 47 minutes ago SKYWORTH Solar Announces Global Launch of Solavita as a Smart Microgrid Brand
Published on 10/30/2026 at 22:49, 1 day 2 hours ago EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE
Published on 10/30/2026 at 18:38, 1 day 6 hours ago EQS-Adhoc: Starcom Holding AD publishes Interim Q3 2026 Financial Report
Published on 10/30/2026 at 23:00, 1 day 2 hours ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 12:00, 1 day 13 hours ago Capital increase through exercise of subscription rights